SCHEMBL5022264

SCHEMBL5022264

COc1cc(CC(=O)O)ccc1OC1CCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.57
GAA P10253 3/20 0.56
ALDH1A1 P00352 2/20 0.56
TSHR P16473 1/20 0.56
NFKB1 P19838 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
RECQL P46063 1/20 0.55
NPSR1 Q6W5P4 1/20 0.51
PDE4A P27815 7/20 0.51
PDE4B Q07343 7/20 0.51
PDE4C Q08493 6/20 0.51
PDE4D Q08499 6/20 0.51
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
SELL P14151 1/20 0.48
SELP P16109 1/20 0.48
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31661693 0.97 RECQL (0.58) CA5AGAAALDH1A1TSHRNFKB1
SCHEMBL6366618 0.97 RECQL (0.58) CA5AGAAALDH1A1TSHRNFKB1
SCHEMBL2371289 0.92 PDE4B (0.60) CA5AGAAALDH1A1TSHRNFKB1
SCHEMBL16327027 0.88 CA5A (0.53) CA5AGAAALDH1A1TSHRNFKB1
Hydrochloric Acid SCHEMBL4717396 0.87 CA5A (0.52) CA5AGAAALDH1A1TSHRNFKB1
SCHEMBL6366896 0.85 RECQL (0.60) RECQLPDE4APDE4BPDE4CPDE4D
SCHEMBL16533505 0.83 RECQL (0.51) CA5AGAAALDH1A1TSHRNFKB1
SCHEMBL153055 0.82 GAA (0.74) CA5AGAAALDH1A1TSHRNFKB1
SCHEMBL30049382 0.82 GAA (0.74) CA5AGAAALDH1A1TSHRNFKB1
SCHEMBL31661761 0.81 CA5A (0.54) CA5AGAAALDH1A1TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058356-A1 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists NEUROCRINE BIOSCIENCES, INC. (US) 2008-03-06 US disclosed
EP-1697351-A1 2,6-BISHETEROARYL-4-AMINOPYRIMIDINES AS ADENOSINE RECEPTOR ANTAGONISTS Almirall Prodesfarma AG (CH) 2006-09-06 EP disclosed
WO-2005058883-A1 2, 6 BISHETEROARYL-4-AMINOPYRIMIDINES AS ADENOSINE RECEPTOR ANTAGONISTS ALMIRALL PRODESFARMA AG (CH) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058356-A1 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists ADORA2A, ADORA3, ADORA1 CA5A 1886/4885GAA 2254/4885ALDH1A1 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.